
Zimmer Biomet: Innovations in Orthopedic Care
Zimmer Biomet is a global medical technology leader offering innovative implants and digital technologies across all stages of the patient journey.
Welcome to Zimmer Biomet Australia and New Zealand
Welcome to Zimmer Biomet Australia & New Zealand, where our commitment to advancing healthcare is built on a legacy of innovation and success. Guided by our mission to alleviate pain and improve …
Zimmer Biomet Product Catalog
Products and solutions from Zimmer BiometAll content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its …
Hip Implants & Replacement Technology Patient Information
Learn more about the benefits and types of hip replacement products and technology from Zimmer Biomet
Get in Touch: Contact Zimmer Biomet Today
Reach out to Zimmer Biomet through various channels including email forms for Grants, Accounts, and HR. Connect with our corporate headquarters.
Advanced Biologics Solutions | Zimmer Biomet
The Zimmer Biomet Biologics product portfolio represents the passionate pursuit of the most innovative and clinically relevant solutions addressing the needs of surgeons and their patients. As a leader in …
Patient-Matched Implants - Zimmer Biomet
Anatomic individuality or extremely difficult reconstructive cases may require the development of a patient-specific implant. In such cases, Zimmer Biomet’s Patient-Matched Implant (PMI ®) …
ROSA® Hip Robotic-Assisted Hip Replacement Patient Information
You’re unique, and so is your individual anatomy. That’s why Zimmer Biomet offers ROSA ® Hip robotic technology for hip replacement surgery. ROSA ®, which stands for Robotic Surgical Assistant, is …
Meet Our Leaders: Zimmer Biomet Leadership
Meet Zimmer Biomet's executive leadership team. Led by Ivan Tornos, they drive the company's mission and vision across diverse fields.
- [PDF]
Annual Report 2024
Zimmer Biomet recorded net sales of $7.679 billion in 2024, an increase of 3.8% compared to 2023 primarily due a combination of market growth, new product introductions, positive price realization …